Study gut microbes and muscle loss in liver cirrhosis
Part of Brain & nervous system, Digestive system clinical trials.
This study looks at the gut microbiome (the helpful bacteria in your gut) and muscle loss (sarcopenia) in people with liver cirrhosis. It may help researchers understand what changes in the gut and body can go along with getting weaker, so better treatments can be developed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old and have a diagnosis of liver cirrhosis (from symptoms, scans, or tissue tests).
- You are currently in the hospital for any reason.
- You can give informed consent (agree to join the study).
- You had a CT or MRI scan within about 14 days before or after the study visit.
- You do not have serious thinking or confusion problems (such as advanced hepatic encephalopathy).
- You do not have advanced liver cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and tissue samples from people with sarcopenia (muscle loss). It uses CT or MRI scans you already have planned to see how muscle changes over time. Your samples help researchers understand why muscle loss happens and how to treat it.
This trial tests whether a special nutrition plan can help treat muscle loss in people with liver cirrhosis who also have fluid buildup that doesn't improve with standard treatment. It aims to improve strength and outcomes after a procedure to place a shunt in the liver.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study uses ultrasound to measure muscle mass in people with cirrhosis. It aims to understand muscle changes and their link to health outcomes.
This study looks at the bacteria in your gut (the microbiome) to understand how they relate to obesity and muscle loss. Researchers will collect stool samples to analyze the gut bacteria, which may help find new ways to treat metabolic diseases.
This study looks at the bacteria in the gut of people with liver cirrhosis to better understand how they relate to the disease. By joining, you help researchers learn more about cirrhosis, which may lead to better care in the future.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.